John D. Carpten

Active 1994–2025

101
Papers
25,285
Citations
71
h-index
97
i10-index

Citations

Citations per year for John D. Carpten1951: 1 citations1987: 1 citations1994: 1 citations1995: 2 citations1996: 9 citations1997: 24 citations1998: 33 citations1999: 52 citations2000: 81 citations2001: 71 citations2002: 99 citations2003: 163 citations2004: 172 citations2005: 131 citations2006: 149 citations2007: 107 citations2008: 209 citations2009: 228 citations2010: 233 citations2011: 233 citations2012: 287 citations2013: 295 citations2014: 274 citations2015: 223 citations2016: 218 citations2017: 236 citations2018: 232 citations2019: 628 citations2020: 656 citations2021: 661 citations2022: 550 citations2023: 343 citations2024: 636 citations2025: 327 citations2026: 12 citations1952–1986: no citations, so these years are not shown1988–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,535 citing papers, 30.7% of this breakdownUnited Kingdom: 853 citing papers, 7.4% of this breakdownChina: 758 citing papers, 6.6% of this breakdownGermany: 579 citing papers, 5% of this breakdownItaly: 522 citing papers, 4.5% of this breakdownCanada: 451 citing papers, 3.9% of this breakdownFrance: 422 citing papers, 3.7% of this breakdownAustralia: 372 citing papers, 3.2% of this breakdownSpain: 299 citing papers, 2.6% of this breakdownNetherlands: 295 citing papers, 2.6% of this breakdownJapan: 272 citing papers, 2.4% of this breakdownSweden: 241 citing papers, 2.1% of this breakdown
0%30.7%Other 25.3%

Fields

  • Biochemistry, Genetics and Molecular Biology49.9%
  • Medicine43%
  • Immunology and Microbiology2.2%
  • Neuroscience1.5%
  • Agricultural and Biological Sciences0.8%
  • Environmental Science0.6%
  • Other2%

Topics

  • Cancer Genomics and Diagnostics5.2%
  • Genomics and Rare Diseases3.1%
  • Multiple Myeloma Research and Treatments2.8%
  • Prostate Cancer Treatment and Research2.7%
  • Genetic Associations and Epidemiology2.1%
  • PI3K/AKT/mTOR signaling in cancer2%
  • Other82.1%

Coauthors

All papers

Open in search
  1. REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rosalind A. Eeles, Zsofia Kote‐Jarai, Carlos D. Bustamante, Daniel J. Schaid, Trevor Hastie, Elaine A. Ostrander, Joan E. Bailey‐Wilson, Predrag Radivojac, Stephen N. Thibodeau, Alice S. Whittemore, Weiva Sieh - The American Journal of Human Genetics 2016 cited by 2,986

  2. Translating RNA sequencing into clinical diagnostics: opportunities and challenges

    Authors: , , , , - Nature Reviews Genetics 2016 cited by 841

  3. A transforming mutation in the pleckstrin homology domain of AKT1 in cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature 2007 cited by 1,295

  4. Spatial Transcriptomic Analysis of a Diverse Patient Cohort Reveals a Conserved Architecture in Triple-Negative Breast Cancer

    Authors: , , , , , , , , , - Cancer Research 2022 cited by 105

  5. African Ancestry–Associated Gene Expression Profiles in Triple-Negative Breast Cancer Underlie Altered Tumor Biology and Clinical Outcome in Women of African Descent

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lee D. Gibbs, Zarko Monojlovic, Rick A. Kittles, Jason White, Clayton Yates, Upender Manne, Kevin Gardner, Nigel P. Mongan, Esther Cheng, Paula S. Ginter, Syed A. Hoda, Olivier Elemento, Nicolas Robine, Andrea Sboner, John D. Carpten, Lisa A. Newman, Melissa B. Davis - Cancer Discovery 2022 cited by 134

  6. Initial genome sequencing and analysis of multiple myeloma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robb Onofrio, Trevor J. Pugh, S. Vincent Rajkumar, Alex H. Ramos, David S. Siegel, Andrey Sivachenko, A. Keith Stewart, Suzanne Trudel, Ravi Vij, Douglas Voet, Wendy Winckler, Todd M. Zimmerman, John D. Carpten, J.M. Trent, William C. Hahn, Levi A. Garraway, Matthew Meyerson, Eric S. Lander, Gad Getz, Todd R. Golub - Nature 2011 cited by 1,455

  7. Detection of Chromosomal Alterations in the Circulation of Cancer Patients with Whole-Genome Sequencing

    Authors: , , , , , , , , , , , - Science Translational Medicine 2012 cited by 634

  8. Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2007 cited by 988

  9. Germline Mutations in HOXB13 and Prostate-Cancer Risk

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 cited by 670

  10. Clonal competition with alternating dominance in multiple myeloma

    Authors: , , , , , , , , , , , , , , , , - Blood 2012 cited by 636

  11. The secreted glycoprotein lubricin protects cartilage surfaces and inhibits synovial cell overgrowth

    Authors: , , , , , , , , , , - Journal of Clinical Investigation 2005 cited by 518

  12. Advancing genomics to improve health equity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lorjetta E. Schools, Jennifer L. Troyer, Benjamin S. Wilfond, Genevieve L. Wojcik, Judy H. Cho, Sandra Soo‐Jin Lee, Eric D. Green - Nature Genetics 2024 cited by 51

  13. Toward precision medicine in glioblastoma: the promise and the challenges

    Authors: , , , , , , , , , , , , , , , , , , , - Neuro-Oncology 2015 cited by 223

  14. Single-cell sequencing of genomic DNA resolves sub-clonal heterogeneity in a melanoma cell line

    Authors: , , , , , , , , , , , - Communications Biology 2020 cited by 69

  15. Applicability of spatial transcriptional profiling to cancer research

    Authors: , , , , - Molecular Cell 2021 cited by 58

  16. Evidence of Novel Susceptibility Variants for Prostate Cancer and a Multiancestry Polygenic Risk Score Associated with Aggressive Disease in Men of African Ancestry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christopher T. Rentsch, Kelly Cho, Benjamin H. McMahon, Richard Biritwum, Andrew A. Adjei, Evelyn Tay, Ann Truelove, Shelley Niwa, Thomas A. Sellers, Kosj Yamoah, Adam B. Murphy, Dana C. Crawford, Alpa V Patel, William S. Bush, Melinda C. Aldrich, Olivier Cussenot, György Petrovics, Jennifer Cullen, Christine Neslund‐Dudas, Mariana C. Stern, Zsofia Kote‐Jarai, Koveela Govindasami, Michael B. Cook, Anand P. Chokkalingam, Ann W. Hsing, Phyllis J. Goodman, Thomas J. Hoffmann, Bettina F. Drake, Jennifer J. Hu, Jacob M. Keaton, Jacklyn N. Hellwege, Peter E. Clark, Mohamed Jalloh, Sérigne Maguèye Gueye, Lamine Niang, Olufemi J. Ogunbiyi, Michael O. Idowu, Olufemi Popoola, Akindele O. Adebiyi, Oseremen I. Aisuodionoe-Shadrach, Hafees O. Ajibola, Mustapha A. Jamda, Olabode P. Oluwole, Maxwell M. Nwegbu, Ben Adusei, Sunny Mante, Afua O.D. Abrahams, James E. Mensah, Halimatou Diop‐Ndiaye, Stephen K. Van Den Eeden, Pascal Blanchet, Jay H. Fowke, Graham Casey, Anselm Hennis, Alexander Lubwama, Ian M. Thompson, Robin J. Leach, Douglas F. Easton, Michael Preuß, Ruth J. F. Loos, Susan Gundell, Peggy Wan, James L. Mohler, Elizabeth T. H. Fontham, Gary J. Smith, Jack A. Taylor, Shiv Srivastava, Rosaline A. Eeles, John D. Carpten, Adam S. Kibel and 18 more - European Urology 2023 cited by 50

  17. Integrated genomic analyses reveal frequent TERT aberrations in acral melanoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Genome Research 2017 cited by 143

  18. Somatic and Germ-Line Mutations of theHRPT2Gene in Sporadic Parathyroid Carcinoma

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2003 cited by 597

  19. Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jessica Aldrich, Ahmet Kurdoglu, Tyler Izatt, Alexis Christoforides, Irene Cherni, Sara Nasser, Rebecca Reiman, L Taylor Phillips, Jackie McDonald, Jonathan Adkins, Stephen D. Mastrian, Pamela Placek, Aprill Watanabe, Janine LoBello, Haiyong Han, Daniel D. Von Hoff, David W. Craig, A. Keith Stewart, John D. Carpten - PLoS Genetics 2014 cited by 342

  20. A somatic reference standard for cancer genome sequencing

    Authors: , , , , , , , , , , , , , , , , , , , , , - Scientific Reports 2016 cited by 91

  21. A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maureen Sanderson, Dana C. Crawford, S. M. Gapstur, William S. Bush, Melinda C. Aldrich, Olivier Cussenot, György Petrovics, Jennifer Cullen, Christine Neslund‐Dudas, Rick A. Kittles, Jianfeng Xu, Mariana C. Stern, Anand P. Chokkalingam, Luc Multigner, Marie‐Élise Parent, F. Ménégaux, Géraldine Cancel‐Tassin, Adam S. Kibel, Eric A. Klein, Phyllis J. Goodman, Janet L. Stanford, Bettina F. Drake, Jennifer J. Hu, Peter E. Clark, Pascal Blanchet, Graham Casey, Anselm Hennis, Alexander Lubwama, Ian M. Thompson, Robin J. Leach, Susan Gundell, Loreall Pooler, James L. Mohler, Elizabeth T. H. Fontham, Gary J. Smith, Jack A. Taylor, Laurent Brureau, William J. Blot, Richard Biritwum, Evelyn Tay, Ann Truelove, Shelley Niwa, Yao Tettey, Rohit Varma, Roberta McKean‐Cowdin, Mina Torres, Mohamed Jalloh, Sérigne Maguèye Gueye, Lamine Niang, Olufemi J. Ogunbiyi, Michael O. Idowu, Olufemi Popoola, Akindele O. Adebiyi, Oseremen I. Aisuodionoe-Shadrach, Maxwell M. Nwegbu, Ben Adusei, Sunny Mante, Afua O.D. Abrahams, Edward D. Yeboah, James E. Mensah, Andrew A. Adjei, Halimatou Diop‐Ndiaye, Michael B. Cook, Stephen J. Chanock, Stephen Watya, Rosalind A. Eeles, Charleston W. K. Chiang, Joseph Lachance, Timothy R. Rebbeck, David V. Conti and 1 more - European Urology 2022 cited by 48

  22. CUL3 and NRF2 Mutations Confer an NRF2 Activation Phenotype in a Sporadic Form of Papillary Renal Cell Carcinoma

    Authors: , , , , , , , , , , - Cancer Research 2013 cited by 159

  23. Enrichment of PI3K-AKT–mTOR Pathway Activation in Hepatic Metastases from Breast Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Clinical Cancer Research 2017 cited by 96

  24. Modulation of Non-Templated Nucleotide Addition by Taq DNA Polymerase: Primer Modifications that Facilitate Genotyping

    Authors: , , - BioTechniques 1996 cited by 1,284